Non-cystic fibrosis bronchiectasis in children: clinical profile, etiology and outcome

Ajay Kumar1, Rakesh Lodha, Prawin Kumar

  • 1Departments of Pediatrics, Vardhaman Mahavir Medical College and Safdarjang Hospital, New Delhi; and *All India Institute of Medical Sciences, New Delhi, India. Correspondence to: Dr SK Kabra, Professor, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. skkabra@hotmail.com.

Indian Pediatrics
|February 2, 2015
PubMed

Insights

Non-cystic fibrosis bronchiectasis in children is often caused by infections or primary ciliary dyskinesia. Early diagnosis is crucial, as many children experience complications, require surgery, or sadly, pass away.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Clinical Research

Background:

  • Non-cystic fibrosis bronchiectasis is a chronic lung condition in children.
  • Understanding its causes and outcomes is vital for effective management.
  • Delayed diagnosis can lead to significant morbidity.

Purpose of the Study:

  • To detail the clinical characteristics, etiological factors, and outcomes.
  • To analyze the profile of pediatric patients with non-cystic fibrosis bronchiectasis.
  • To highlight the importance of timely diagnosis and intervention.

Main Methods:

  • Retrospective chart review of 80 children diagnosed with non-cystic fibrosis bronchiectasis.
  • Data collected from a pediatric chest clinic at a tertiary care hospital.
  • Analysis of clinical presentation, identified causes, and patient outcomes.

Main Results:

  • Etiology identified in 63.8% of cases; common causes include post-infectious (23.8%) and primary ciliary dyskinesia (15%).
  • Complications occurred in 95% of patients.
  • Surgery was needed for 17.5%, and mortality was 11.1%.

Conclusions:

  • Post-infectious causes and primary ciliary dyskinesia are frequent in pediatric non-cystic fibrosis bronchiectasis.
  • Increased awareness is needed for earlier diagnosis to improve outcomes.
  • Delayed diagnosis is a significant issue impacting patient prognosis.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
2
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
655
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
2
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
2
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K